Adage Capital Partners Gp, L.L.C. Axsome Therapeutics, Inc. Transaction History

Adage Capital Partners Gp, L.L.C.

$59.7 Billion
Q3 2025

A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 445,000 shares of AXSM stock, worth $62.2 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

445,000

Previous 447,000 0.45%

Holding current value

$62.2 Million

Previous $46.7 Million 15.82%

% of portfolio

0.09%

Previous 0.08%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	SELL	$100.39 - $129.29 $200,780 - $258,579	-2,000 Reduced 0.45%	445,000 $54 Million
Q2 2025 Aug 14, 2025	BUY	$95.65 - $116.49 $38.2 Million - $46.5 Million	399,000 Added 831.25%	447,000 $46.7 Million
Q1 2025 May 15, 2025	SELL	$80.05 - $137.75 $960,600 - $1.65 Million	-12,000 Reduced 20.0%	48,000 $5.6 Million
Q4 2024 Feb 14, 2025	SELL	$83.08 - $100.49 $38.6 Million - $46.7 Million	-465,000 Reduced 88.57%	60,000 $5.08 Million
Q3 2024 Nov 14, 2024	SELL	$78.93 - $95.84 $16.2 Million - $19.6 Million	-205,000 Reduced 28.08%	525,000 $47.2 Million
Q2 2024 Aug 14, 2024	BUY	$65.72 - $80.5 $14.1 Million - $17.3 Million	215,000 Added 41.75%	730,000 $58.8 Million
Q1 2024 May 15, 2024	BUY	$69.39 - $97.64 $10.4 Million - $14.6 Million	150,000 Added 41.1%	515,000 $41.1 Million
Q4 2023 Feb 14, 2024	BUY	$57.42 - $83.61 $2.3 Million - $3.34 Million	40,000 Added 12.31%	365,000 $29.1 Million
Q3 2023 Nov 14, 2023	SELL	$69.25 - $82.21 $8.27 Million - $9.82 Million	-119,417 Reduced 26.87%	325,000 $22.7 Million
Q2 2023 Aug 14, 2023	SELL	$58.41 - $90.35 $35.4 Million - $54.7 Million	-605,583 Reduced 57.67%	444,417 $31.9 Million
Q1 2023 May 15, 2023	SELL	$58.39 - $75.0 $875,850 - $1.13 Million	-15,000 Reduced 1.41%	1,050,000 $64.8 Million
Q4 2022 Feb 14, 2023	BUY	$39.94 - $79.72 $36.5 Million - $72.9 Million	915,000 Added 610.0%	1,065,000 $82.1 Million
Q3 2022 Nov 14, 2022	SELL	$36.06 - $69.85 $22.8 Million - $44.3 Million	-633,662 Reduced 80.86%	150,000 $6.69 Million
Q2 2022 Aug 15, 2022	BUY	$21.74 - $46.75 $2.91 Million - $6.25 Million	133,662 Added 20.56%	783,662 $30 Million
Q1 2022 May 16, 2022	BUY	$23.7 - $41.39 $15.4 Million - $26.9 Million	650,000 New	650,000 $26.9 Million
Q4 2020 Feb 16, 2021	SELL	$66.31 - $86.52 $13.3 Million - $17.3 Million	-200,000 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$49.87 - $98.69 $5.74 Million - $11.3 Million	115,000 Added 135.29%	200,000 $16.5 Million
Q1 2020 May 15, 2020	BUY	$41.2 - $101.31 $3.5 Million - $8.61 Million	85,000 New	85,000 $5 Million

Others Institutions Holding AXSM

# of Institutions

414

Shares Held

36.8M

Call Options Held

752K

Put Options Held

567K

View Full List

About Axsome Therapeutics, Inc.

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $5.99B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

More about AXSM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Adage Capital Partners Gp, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Adage Capital Partners Gp, L.L.C. with notifications on news.

Account

Adage Capital Partners Gp, L.L.C. Axsome Therapeutics, Inc. Transaction History